Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 11-20 of 32

Page
per page
  1. Chloroquine diphosphate
    A8628 Chloroquine diphosphate
     1 Citation
    Target: Autophagy
    Summary: Antimalarial drug,TLR7 TLR9 inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL
  2. DBeQ
    A8629 DBeQ
    Target: P97 ATPase
    Summary: P97 ATPase inhibitor
      ≥16 mg/mL
  3. Xanthohumol
    A8630 Xanthohumol
    Summary: VCP inhibitor
      ≥121.6 mg/mL
  4. FK 866 hydrochloride
    A8631 FK 866 hydrochloride
    Target: NMPRTase
    Summary: NMPRTase inhibitor
      ≥18.95 mg/mL
  5. (±)-Bay K 8644
    A8632 (±)-Bay K 8644
    Summary: L-type Ca2+-channel activator
      ≥36.2 mg/mL
  6. Concanamycin A
    A8633 Concanamycin A
     1 Citation
    Target: Vacuolar-type ATPase
    Summary: V-type (vacuolar) H+-ATPase inhibitor
      soluble in DMSO
  7. Trifluoperazine 2HCl
    B1397 Trifluoperazine 2HCl
    Summary: Dopamine D2 receptor inhibitor
      ≥24.02 mg/mL
  8. Sulfacetamide Sodium
    B1395 Sulfacetamide Sodium
    Summary: Sulfonamide antibiotic
      ≥10.65 mg/mL
  9. Divalproex Sodium
    B1391 Divalproex Sodium
    Summary: Epilepsy/migraines/bipolar disorder medicine
      ≥14.2 mg/mL
  10. Pepstatin A
    A2571 Pepstatin A
     1 Citation
    Target: Cathepsins|Renin|HIV proteases|Pepsins
    Summary: Aspartic protease inhibitor
      ≥34.3 mg/mL

Items 11-20 of 32

Page
per page